• New Developments in the Understanding of Epilepsy and the Application of Antiepileptic Therapies
  • Brown Bag Consult: I'm Not Feeling Well
  • Pharmacy Sues DEA for Seizing Its Drugs
  • Confronting the Challenge of Health Care–Associated Infections
  • Checking Long-Term Care Blister Packs and Bingo Cards
  • Can You Read These Rxs? (November 2014)

Breaking News

Lundbeck Discontinues Development of Experimental Stroke Drug Compound
Lundbeck will cease further development of its experimental desmoteplase compound for ischemic stroke.
Routine pediatric multivitamin use is not endorsed by any major medical association because it is considered unnecessary for almost every young patient. Regardless, many parents rely on multivitamins for their children, especially in households where balanced nutrition is difficult or impossible due to time or money constraints.
Responding to a request from state officials to provide greater access to naloxone, CVS Health, Walgreens, and other chain pharmacies will stock and dispense the opioid overdose antidote in stores across Maryland, as well as train their pharmacists on administering the lifesaving medication.
Taking another step toward preventing and treating inflammatory bowel disease (IBD), an international team of investigators has determined that the gut bacteria behind Crohn’s disease and ulcerative colitis may be inherited, and antibiotics can make those patients’ gut imbalance worse.
A collaborative, pharmacist-led intervention targeted at health care professionals improves statin prescribing and lowers the risk of atherosclerotic events in patients with cardiovascular disease.
Baxter International is voluntarily recalling 2 lots of its 0.9% sodium chloride injection due to complaints of particle matter.
A new FDA-approved drug could help treat complicated intra-abdominal infections and complicated urinary tract infections among adults.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues
$auto_registration$